Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionnicotinic acid receptor activity

HCAR2 HCAR3

5.53e-0521492GO:0070553
GeneOntologyMolecularFunctionserine-type endopeptidase activity

PCSK5 ST14 GZMK KLK9 PLAU KLK5 PLG MMP19

9.20e-051901498GO:0004252
GeneOntologyMolecularFunctionserine-type peptidase activity

PCSK5 ST14 GZMK KLK9 PLAU KLK5 PLG MMP19

1.66e-042071498GO:0008236
GeneOntologyMolecularFunctionserine hydrolase activity

PCSK5 ST14 GZMK KLK9 PLAU KLK5 PLG MMP19

1.96e-042121498GO:0017171
DomainCUB

CUBN CSMD2 ST14 CSMD1 SEZ6

3.94e-05491465PF00431
DomainCUB

CUBN CSMD2 ST14 CSMD1 SEZ6

4.35e-05501465SM00042
Domain-

CUBN CSMD2 ST14 CSMD1 SEZ6

5.27e-055214652.60.120.290
DomainCUB

CUBN CSMD2 ST14 CSMD1 SEZ6

5.78e-05531465PS01180
DomainCG-1

CAMTA2 CAMTA1

6.07e-0521462SM01076
DomainCG_1

CAMTA2 CAMTA1

6.07e-0521462PS51437
DomainCG-1

CAMTA2 CAMTA1

6.07e-0521462PF03859
DomainHCAR2/3_rcpt

HCAR2 HCAR3

6.07e-0521462IPR028017
DomainCG-1_dom

CAMTA2 CAMTA1

6.07e-0521462IPR005559
DomainTRYPSIN_SER

ST14 GZMK KLK9 PLAU KLK5 PLG

7.47e-05901466IPR033116
DomainCUB_dom

CUBN CSMD2 ST14 CSMD1 SEZ6

8.23e-05571465IPR000859
DomainTRYPSIN_HIS

ST14 GZMK KLK9 PLAU KLK5 PLG

1.58e-041031466IPR018114
DomainTRYPSIN_SER

ST14 GZMK KLK9 PLAU KLK5 PLG

1.85e-041061466PS00135
DomainTRYPSIN_HIS

ST14 GZMK KLK9 PLAU KLK5 PLG

1.95e-041071466PS00134
DomainPeptidase_S1A

ST14 GZMK KLK9 PLAU KLK5 PLG

2.62e-041131466IPR001314
DomainTRYPSIN_DOM

ST14 GZMK KLK9 PLAU KLK5 PLG

2.88e-041151466PS50240
DomainTryp_SPc

ST14 GZMK KLK9 PLAU KLK5 PLG

3.16e-041171466SM00020
DomainTrypsin_dom

ST14 GZMK KLK9 PLAU KLK5 PLG

3.78e-041211466IPR001254
DomainTrypsin

ST14 GZMK KLK9 PLAU KLK5 PLG

3.78e-041211466PF00089
DomainPeptidase_S1_PA

ST14 GZMK KLK9 PLAU KLK5 PLG

4.13e-041231466IPR009003
DomainQuino_amine_DH_bsu

NID2 NBAS WDR86

6.46e-04221463IPR011044
DomainGF_recep_IV

PCSK5 ERBB4

8.92e-0461462PF14843
DomainGF_recep_IV

PCSK5 ERBB4

8.92e-0461462IPR032778
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

VWA5B2 SEMA3F PCSK5 NDST1 MAN2B1 SZT2 INPPL1 TMCO6 ZFPM1 TRRAP BIRC6 ST14 ITPR2 VAC14 PIK3C2B FANCI ZFYVE26 WDR90 CABIN1 IL17RD

6.76e-0811051502035748872
Pubmed

A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.

NEMP1 NDST1 ZFYVE27 TTPAL TRRAP BIRC6 RIN1 KSR1 RNF167 TELO2 MFSD8 FLRT3 NUP160

1.55e-057191501335337019
Pubmed

Activated niacin receptor HCA2 inhibits chemoattractant-mediated macrophage migration via Gβγ/PKC/ERK1/2 pathway and heterologous receptor desensitization.

HCAR2 HCAR3

1.85e-052150228186140
Pubmed

Initiation of plasminogen activation on the surface of monocytes expressing the type II transmembrane serine protease matriptase.

ST14 PLAU

1.85e-052150216794252
Pubmed

The Immunometabolomic Interface Receptor Hydroxycarboxylic Acid Receptor 2 Mediates the Therapeutic Effects of Dimethyl Fumarate in Autoantibody-Induced Skin Inflammation.

HCAR2 HCAR3

1.85e-052150230154797
Pubmed

The role of HCA2 (GPR109A) in regulating macrophage function.

HCAR2 HCAR3

1.85e-052150223882124
Pubmed

The ubiquitin-conjugating DNA repair enzyme HR6A is a maternal factor essential for early embryonic development in mice.

UBE2A UBE2B

1.85e-052150215169909
Pubmed

Crosstalk between microbiome, regulatory T cells and HCA2 orchestrates the inflammatory response in a murine psoriasis model.

HCAR2 HCAR3

1.85e-052150236891315
Pubmed

Loss of HR6B ubiquitin-conjugating activity results in damaged synaptonemal complex structure and increased crossing-over frequency during the male meiotic prophase.

UBE2A UBE2B

1.85e-052150212556476
Pubmed

Parabacteroides distasonis ameliorates insulin resistance via activation of intestinal GPR109a.

HCAR2 HCAR3

1.85e-052150238007572
Pubmed

The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin.

PLAU PLG

1.85e-05215024226004
Pubmed

Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE.

HCAR2 HCAR3

1.85e-052150224691444
Pubmed

Butyrate ameliorates caerulein-induced acute pancreatitis and associated intestinal injury by tissue-specific mechanisms.

HCAR2 HCAR3

1.85e-052150231347703
Pubmed

Structural and functional conservation of two human homologs of the yeast DNA repair gene RAD6.

UBE2A UBE2B

1.85e-05215021717990
Pubmed

Loss of GPR109A/HCAR2 induces aging-associated hepatic steatosis.

HCAR2 HCAR3

1.85e-052150230659164
Pubmed

Expression and localization of GPR109A (PUMA-G/HM74A) mRNA and protein in mammalian retinal pigment epithelium.

HCAR2 HCAR3

1.85e-052150219223991
Pubmed

Inhibition of tumor invasion by genomic down-regulation of matriptase through suppression of activation of receptor-bound pro-urokinase.

ST14 PLAU

1.85e-052150214747469
Pubmed

Niacin increases adiponectin and decreases adipose tissue inflammation in high fat diet-fed mice.

HCAR2 HCAR3

1.85e-052150223967184
Pubmed

Involvement of the Niacin Receptor GPR109a in the LocalControl of Glucose Uptake in Small Intestine of Type 2Diabetic Mice.

HCAR2 HCAR3

1.85e-052150226371038
Pubmed

Localization of two human homologs, HHR6A and HHR6B, of the yeast DNA repair gene RAD6 to chromosomes Xq24-q25 and 5q23-q31.

UBE2A UBE2B

1.85e-05215021559696
Pubmed

Alloreactive T cells deficient of the short-chain fatty acid receptor GPR109A induce less graft-versus-host disease.

HCAR2 HCAR3

1.85e-052150234653248
Pubmed

Phenolic acids suppress adipocyte lipolysis via activation of the nicotinic acid receptor GPR109A (HM74a/PUMA-G).

HCAR2 HCAR3

1.85e-052150219136666
Pubmed

G Protein-Coupled Receptor 109A Maintains the Intestinal Integrity and Protects Against ETEC Mucosal Infection by Promoting IgA Secretion.

HCAR2 HCAR3

1.85e-052150233488584
Pubmed

Lactate-induced activation of HCA2 improves survival in mice with sepsis.

HCAR2 HCAR3

1.85e-052150230951370
Pubmed

Niacin Ameliorates Hepatic Steatosis by Inhibiting De Novo Lipogenesis Via a GPR109A-Mediated PKC-ERK1/2-AMPK Signaling Pathway in C57BL/6 Mice Fed a High-Fat Diet.

HCAR2 HCAR3

1.85e-052150231858105
Pubmed

Exploring the role of the metabolite-sensing receptor GPR109a in diabetic nephropathy.

HCAR2 HCAR3

1.85e-052150232068460
Pubmed

DONSON is required for CMG helicase assembly in the mammalian cell cycle.

DONSON CDC45

1.85e-052150237781960
Pubmed

The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome.

HCAR2 HCAR3

1.85e-052150230657794
Pubmed

The NMR structure of the class I human ubiquitin-conjugating enzyme 2b.

UBE2A UBE2B

1.85e-052150211885984
Pubmed

Melatonin alleviates titanium nanoparticles induced osteolysis via activation of butyrate/GPR109A signaling pathway.

HCAR2 HCAR3

1.85e-052150234092246
Pubmed

Receptor mediated binding of the fibrinolytic components, plasminogen and urokinase, to peripheral blood cells.

PLAU PLG

1.85e-05215022829380
Pubmed

Ataxia and Purkinje cell degeneration in mice lacking the CAMTA1 transcription factor.

CAMTA2 CAMTA1

1.85e-052150225049392
Pubmed

Molecular identification of high and low affinity receptors for nicotinic acid.

HCAR2 HCAR3

1.85e-052150212522134
Pubmed

G Protein-Coupled Receptor 109A and Host Microbiota Modulate Intestinal Epithelial Integrity During Sepsis.

HCAR2 HCAR3

1.85e-052150230271409
Pubmed

Niacin fine-tunes energy homeostasis through canonical GPR109A signaling.

HCAR2 HCAR3

1.85e-052150230596513
Pubmed

The niacin receptor HCAR2 modulates microglial response and limits disease progression in a mouse model of Alzheimer's disease.

HCAR2 HCAR3

1.85e-052150235320002
Pubmed

Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients.

CSMD2 CSMD1

1.85e-052150224408017
Pubmed

GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing.

HCAR2 HCAR3

1.85e-052150216322797
Pubmed

Nicotinic acid receptor agonists.

HCAR2 HCAR3

1.85e-052150218983141
Pubmed

Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms.

HCAR2 HCAR3

1.85e-052150231366236
Pubmed

Role of RIN1 on telomerase activity driven by EGF-Ras mediated signaling in breast cancer.

TERT RIN1

1.85e-052150233069695
Pubmed

On the pivotal role of Elovl3/ELOVL3 in meibogenesis and ocular physiology of mice.

ACADS ELOVL3

1.85e-052150231208226
Pubmed

Alternative Splicing of RAD6B and Not RAD6A is Selectively Increased in Melanoma: Identification and Functional Characterization.

UBE2A UBE2B

1.85e-052150231683936
Pubmed

GPR109A gene deletion ameliorates gonadectomy-induced bone loss in mice.

HCAR2 HCAR3

1.85e-052150235489706
Pubmed

Deorphanization of GPR109B as a receptor for the beta-oxidation intermediate 3-OH-octanoic acid and its role in the regulation of lipolysis.

HCAR2 HCAR3

1.85e-052150219561068
Pubmed

The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival.

HCAR2 HCAR3

1.85e-052150224371223
Pubmed

High dietary niacin may increase prostaglandin formation but does not increase tumor formation in ApcMin/+ mice.

HCAR2 HCAR3

1.85e-052150221774590
Pubmed

RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance.

UBE2A UBE2B

1.85e-052150228806395
Pubmed

GPR109a Regulates Phenotypic and Functional Alterations in Macrophages and the Progression of Type 1 Diabetes.

HCAR2 HCAR3

1.85e-052150236208084
Pubmed

The role of the C-terminus of the human hydroxycarboxylic acid receptors 2 and 3 in G protein activation using Gα-engineered yeast cells.

HCAR2 HCAR3

1.85e-052150226656756
Pubmed

Biased allosteric activation of ketone body receptor HCAR2 suppresses inflammation.

HCAR2 HCAR3

1.85e-052150237597514
Pubmed

The Role of GPR109a Signaling in Niacin Induced Effects on Fed and Fasted Hepatic Metabolism.

HCAR2 HCAR3

1.85e-052150233924461
Pubmed

Ketone Body 3-Hydroxybutyrate Ameliorates Atherosclerosis via Receptor Gpr109a-Mediated Calcium Influx.

HCAR2 HCAR3

1.85e-052150233977048
Pubmed

PUMA-G, an IFN-gamma-inducible gene in macrophages is a novel member of the seven transmembrane spanning receptor superfamily.

HCAR2 HCAR3

1.85e-052150211745392
Pubmed

Niacin-induced hyperglycemia is partially mediated via niacin receptor GPR109a in pancreatic islets.

HCAR2 HCAR3

1.85e-052150225622782
Pubmed

GPR109A mediates the effects of hippuric acid on regulating osteoclastogenesis and bone resorption in mice.

HCAR2 HCAR3

1.85e-052150233420329
Pubmed

Molecular identification of nicotinic acid receptor.

HCAR2 HCAR3

1.85e-052150212646212
Pubmed

PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect.

HCAR2 HCAR3

1.85e-052150212563315
Pubmed

A key role for the urokinase plasminogen activator (uPA) in invasive Group A streptococcal infection.

PLAU PLG

1.85e-052150223853591
Pubmed

Physiological effects of inactivation and the roles of Elovl3/ELOVL3 in maintaining ocular homeostasis.

ACADS ELOVL3

1.85e-052150233455016
Pubmed

Deficiency of metabolite sensing receptor HCA2 impairs the salutary effect of niacin in hemorrhagic shock.

HCAR2 HCAR3

1.85e-052150230625381
Pubmed

Ketones and pain: unexplored role of hydroxyl carboxylic acid receptor type 2 in the pathophysiology of neuropathic pain.

HCAR2 HCAR3

1.85e-052150230085883
Pubmed

Nicotinic acid receptor abnormalities in human skin cancer: implications for a role in epidermal differentiation.

HCAR2 HCAR3

1.85e-052150221655214
Pubmed

A genetic association study of CSMD1 and CSMD2 with cognitive function.

CSMD2 CSMD1

1.85e-052150227890662
Pubmed

(D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G.

HCAR2 HCAR3

1.85e-052150215929991
Pubmed

Activation of HCA2 regulates microglial responses to alleviate neurodegeneration in LPS-induced in vivo and in vitro models.

HCAR2 HCAR3

1.85e-052150236991440
Pubmed

Inflammation stimulates niacin receptor (GPR109A/HCA2) expression in adipose tissue and macrophages.

HCAR2 HCAR3

1.85e-052150225320346
Pubmed

A novel family of calmodulin-binding transcription activators in multicellular organisms.

CAMTA2 CAMTA1

1.85e-052150211925432
Pubmed

Nicotinic acid inhibits glucose-stimulated insulin secretion via the G protein-coupled receptor PUMA-G in murine islet β cells.

HCAR2 HCAR3

1.85e-052150221441844
Pubmed

The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia.

CSMD2 CSMD1

1.85e-052150221439553
Pubmed

A joint study of whole exome sequencing and structural MRI analysis in major depressive disorder.

CNTNAP5 CSMD1

1.85e-052150230722798
Pubmed

BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.

HCAR2 HCAR3

1.85e-052150231914599
Pubmed

Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP.

PLAU KLK5

1.85e-052150233896830
Pubmed

Subunits of the Pyruvate Dehydrogenase Cluster of Mycoplasma pneumoniae Are Surface-Displayed Proteins that Bind and Activate Human Plasminogen.

PLAU PLG

1.85e-052150225978044
Pubmed

Modulation of HDL metabolism by the niacin receptor GPR109A in mouse hepatocytes.

HCAR2 HCAR3

1.85e-052150220655299
Pubmed

Evidence for constitutive dimerization of niacin receptor subtypes.

HCAR2 HCAR3

1.85e-052150220380810
Pubmed

GPR109A Expression in the Murine Min6 Pancreatic Beta Cell Line, and Its Relation with Glucose Metabolism and Inflammation.

HCAR2 HCAR3

1.85e-052150226116596
Pubmed

Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen.

PLG MMP19

1.85e-052150221787393
Pubmed

Expression and activation of the ketone body receptor HCAR2/GPR109A promotes preservation of retinal endothelial cell barrier function.

HCAR2 HCAR3

1.85e-052150235649469
Pubmed

GPR109A expressed on medullary thymic epithelial cells affects thymic Treg development.

HCAR2 HCAR3

1.85e-052150237595951
Pubmed

The hypophagic response to heat stress is not mediated by GPR109A or peripheral β-OH butyrate.

HCAR2 HCAR3

1.85e-052150226936786
Pubmed

Hydroxycarboxylic Acid Receptor 2, a Pleiotropically Linked Receptor for the Multiple Sclerosis Drug, Monomethyl Fumarate. Possible Implications for the Inflammatory Response.

HCAR2 HCAR3

1.85e-052150234084164
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

NEMP1 KDM3A GAPVD1 SZT2 ANKRD50 CEMIP2 AGO4 TELO2 FAM20B WDR90 FLRT3

2.02e-055291501114621295
Pubmed

Functional interaction of ubiquitin ligase RNF167 with UBE2D1 and UBE2N promotes ubiquitination of AMPA receptor.

RNF167 UBE2A UBE2B

5.12e-0517150333650289
Pubmed

Lactational competence and involution of the mouse mammary gland require plasminogen.

PLAU PLG

5.53e-053150211003846
Pubmed

Identification of two new members of the CSMD gene family.

CSMD2 CSMD1

5.53e-053150212906867
Pubmed

Hyperhomocysteinemia is detrimental to pregnancy in mice and is associated with preterm birth.

HCAR2 HCAR3

5.53e-053150223579073
Pubmed

Short-chain fatty acids directly exert anti-inflammatory responses in podocytes and tubular epithelial cells exposed to high glucose.

HCAR2 HCAR3

5.53e-053150237215085
Pubmed

Colonic gene expression in conventional and germ-free mice with a focus on the butyrate receptor GPR109A and the butyrate transporter SLC5A8.

HCAR2 HCAR3

5.53e-053150220033346
Pubmed

The human RAD18 gene product interacts with HHR6A and HHR6B.

UBE2A UBE2B

5.53e-053150210908344
Pubmed

International Union of Basic and Clinical Pharmacology. LXXXII: Nomenclature and Classification of Hydroxy-carboxylic Acid Receptors (GPR81, GPR109A, and GPR109B).

HCAR2 HCAR3

5.53e-053150221454438
Pubmed

Staphylokinase reduces plasmin formation by endogenous plasminogen activators.

PLAU PLG

5.53e-053150218331597
Pubmed

Activation of microglial GPR109A alleviates thermal hyperalgesia in female lupus mice by suppressing IL-18 and glutamatergic synaptic activity.

HCAR2 HCAR3

5.53e-053150234919284
Pubmed

The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages.

HCAR2 HCAR3

5.53e-053150224845831
Pubmed

Oral Dimethyl Fumarate Targets HCA2-Expressing Skin Cells in the Imiquimod Mouse Model.

HCAR2 HCAR3

5.53e-053150235189149
Pubmed

The Butyrate-Producing Bacterium Clostridium butyricum Suppresses Clostridioides difficile Infection via Neutrophil- and Antimicrobial Cytokine-Dependent but GPR43/109a-Independent Mechanisms.

HCAR2 HCAR3

5.53e-053150233597149
Pubmed

Enhanced genomic instability and defective postreplication repair in RAD18 knockout mouse embryonic stem cells.

UBE2A UBE2B

5.53e-053150212509447
Pubmed

Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells.

HCAR2 HCAR3

5.53e-053150217008386
Pubmed

Effects of high fat diet on GPR109A and GPR81 gene expression.

HCAR2 HCAR3

5.53e-053150222842580
Pubmed

Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression.

HCAR2 HCAR3

5.53e-053150222914621
GeneFamilyHydroxy-carboxylic acid receptors

HCAR2 HCAR3

8.52e-053972200
GeneFamilyVPS9 domain containing

GAPVD1 RIN1

1.25e-0310972928
GeneFamilyUbiquitin conjugating enzymes E2

BIRC6 UBE2A UBE2B

1.38e-0341973102
CoexpressionONDER_CDH1_TARGETS_2_DN

SEMA3F FZD3 SCEL AKR1C1 ST14 BDKRB2 SLC5A1 DUOX1 P2RX5 PLAU FLRT3 KLK5

1.77e-0547314912M4306
CoexpressionGSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP

PCSK5 SZT2 UBA2 CAMTA2 TRRAP NBAS ASMTL ZFYVE26

1.98e-052001498M5227
CoexpressionGSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP

FBXO48 KLHL28 ITGA2B BDKRB2 CERS5 CAMTA1 BMP15

2.18e-051471497M6085
ToppCellCV-Moderate-7|CV / Virus stimulation, Condition and Cluster

GAPVD1 DOCK8 TMEM161B FANCL BIRC6 DIPK2A ITPR2 NBAS

2.34e-0718615088571956890fc9894d766ba294a28e376b4aba428
ToppCell390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells)

KDM3A ATP13A4 ASTE1 CAMTA2 SCEL PARP14 ST14 FLRT3

3.22e-07194150888db9f9e80c20ff3474f1f6459dcbdc25aec0b6d
ToppCell390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells)

KDM3A ATP13A4 ASTE1 CAMTA2 SCEL PARP14 ST14 FLRT3

3.22e-071941508a71728202493d4858342ea2756ea281cd0d99a3a
ToppCellCOVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type

CACNA1A STXBP5L FAM178B CSMD2 CNTNAP5 KLK5 CSMD1

6.55e-071461507c55f1bdb6ac43b4118cb27ea7c879527e1afcbab
ToppCellChildren_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

ATP13A4 ERBB4 PIDD1 AKR1C1 DUOX1 SRGAP3 CYP4X1

1.07e-0615715076ee2692f705bdd93ba523dffaf2f0cd921b47e28
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FLT4 ANKRD50 CDC45 FANCI ADGRF5 FAM124B SMAD9

3.07e-061841507688428103e8b19f45f2f65d70a0f30c904c8411c
ToppCellCV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster

GAPVD1 DOCK8 TMEM161B FANCL BIRC6 DIPK2A NBAS

3.18e-061851507a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCellControl-Epithelial_cells|Control / group, cell type (main and fine annotations)

PPP4R1 ATP13A4 ERBB4 SCEL DNAH14 DUOX1 ADGRF5

3.54e-061881507707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCellCD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster

GAPVD1 TMEM161B PARP14 BIRC6 CEMIP2 DIPK2A NBAS

3.92e-0619115079454f642c3621370fa23640b631301346b300950
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

NID2 ATP13A4 ABCA4 SCEL PTPRU CYP4X1 FLRT3

4.97e-061981507b598ab958e31f1e98bd06dc0097b58ac3a3f90a3
ToppCellTracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

GABRE SEMA3F PCSK5 EDN2 DUOX1 FLRT3 CSMD1

5.14e-06199150794a7867e800df352731796de8c24cba133c29622
ToppCell390C-Lymphocytic-NK_cells-NK_cell_D2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

LCN12 DNAH14 NBAS GZMK WDR90 SMAD9

1.29e-051521506595afcfa8b161e291fcaf2afc7336bac9b6fae0f
ToppCellThalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)|Thalamus / BrainAtlas - Mouse McCarroll V32

ABCA4 TERT FANCI WDR86 MMP19

1.50e-05921505bbaf5a131f860198840e34843b7c841bcc98d9c4
ToppCellThalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)-|Thalamus / BrainAtlas - Mouse McCarroll V32

ABCA4 TERT FANCI WDR86 MMP19

1.50e-05921505e6aa2b8ca9235a7291ee41d976b886fec185835d
ToppCell10x5'-Lung-Lymphocytic_T_CD4/8-lo|Lung / Manually curated celltypes from each tissue

CEMIP2 CPNE6 FANCI GZMK SLA2 CDC20

1.79e-051611506a1f10e04836848b1deaf295fae033f54d1572fcd
ToppCell390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

KDM3A ATP13A4 ASTE1 CAMTA2 SCEL PARP14

2.35e-051691506665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5
ToppCell390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

KDM3A ATP13A4 ASTE1 CAMTA2 SCEL PARP14

2.35e-0516915066614c9851537e4c21b1e45ff0cc3bad07ef9d034
ToppCellnormal_Pleural_Fluid-T/NK_cells-Cytotoxic_CD8+_T|normal_Pleural_Fluid / Location, Cell class and cell subclass

ERBB4 IL20RA SUN2 GZMK CHST12 SLA2

2.51e-0517115066be81c20f4e962b414afcedfe478dd59c510d1e1
ToppCellPND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

FBXO48 CACNA1A FLT4 BDKRB2 RIN1 ADGRF5

2.59e-051721506490745024730df6357f6c2b81d7a64e21557c0d5
ToppCellNS-moderate-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

PDE9A ITPR2 CNTNAP5 OSBPL1A ADGRF5 SMAD9

3.05e-05177150699500aed584f793aaf308f8afbf5d1c6a9b4ee55
ToppCellFrontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Fos_(Deep_layer_pyramidal_cells_(IEG))-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

TERT EDN2 GARIN2 SLC5A1

3.06e-055315041593743b4ab678670e569c3e68174f508ad8e843
ToppCellFrontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Fos_(Deep_layer_pyramidal_cells_(IEG))|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

TERT EDN2 GARIN2 SLC5A1

3.06e-055315043f206f9c095676e0abb889306a36608b08b0fce3
ToppCell343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|343B / Donor, Lineage, Cell class and subclass (all cells)

ZFYVE27 DIPK2A INTS13 GZMK SLA2 SEZ6

3.15e-0517815065289ac61637224ae70ffbc2d164d73116f10af40
ToppCellTCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9

FLT4 DOCK8 CSMD2 ADGRF5 FAM124B MMP19

3.25e-051791506cc079ba015326dccde955c5eafa3e4a2e40de192
ToppCelldroplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SEMA3F FLT4 DTX1 ST14 CEMIP2 FLRT3

3.45e-051811506cef034030e6b029a49ae56be37ea1fac1a5c350e
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

ERBB4 SCEL EDN2 CYP4X1 KLK5 TMEM151A

3.90e-051851506492529121cb9e88bd3c0db6b54af3cd2979572bc
ToppCellAnterior_Cingulate_gyrus_(CgG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

GABRE PCSK5 ERBB4 ANKRD50 DNAH14 CPNE6

4.02e-05186150632af3f211f9ad5d5c6b86b83325cfbf2f8466b56
ToppCell368C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells)

ATP13A4 TTPAL CDC45 SLA2 GPAT2 LRRC75A

4.02e-0518615065cadab3271fce9ab6da3d7ba9827b8a221cac166
ToppCell10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SEMA3F NID2 ABCA4 CUBN BDKRB2 ADGRF5

4.53e-05190150606bfb62b94b0faf467ef93d5bc5d08924c770098
ToppCellwk_20-22-Hematologic_Lymphocytic-NK-CD56bright_NK|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

CEMIP2 GPR68 SUN2 GZMK CHST12 SLA2

4.53e-051901506c8031df82c3662ce4140c850277987f7210e9bcd
ToppCellCOVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations)

ERBB4 AKR1C1 BDKRB2 SLC5A1 SRGAP3 CYP4X1

4.53e-05190150651ca9ef4df3220487152fcf684147730637c7cc1
ToppCelldroplet-Tongue-nan-3m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KDM5B ATP13A4 SCEL SLC5A1 ITPR2 ETNK2

4.66e-051911506abdd93b2313e635f75a750d051a6a01ddc4e2df9
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ATP13A4 ERBB4 DUOX1 CYP4X1 ADGRF5 FLRT3

4.80e-05192150629f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCellfacs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

VWA5B2 CACNA1A STXBP5L CPNE6 CSMD1 SEZ6

4.94e-051931506be28070c049e7cb68bcd54f582226eb2f5e4bc1c
ToppCellfacs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

VWA5B2 CACNA1A STXBP5L CPNE6 CSMD1 SEZ6

4.94e-0519315060c652ebe22ce5d2927599dd97ef1920547858395
ToppCellfacs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

VWA5B2 CACNA1A STXBP5L CPNE6 CSMD1 SEZ6

4.94e-0519315068689a70a33a7c3823dc647d41ac0160e7c3ae396
ToppCellnucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

ATP13A4 ERBB4 SCEL DNAH14 DUOX1 ADGRF5

5.08e-05194150653f3e49e91b1096f3226010e2de767efb490dfe4
ToppCellnucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

ATP13A4 ERBB4 SCEL DNAH14 DUOX1 ADGRF5

5.23e-0519515069406866f99555198a9be311fbd65751b70f35446
ToppCellfacs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SEMA3F FLT4 DTX1 TTPAL CEMIP2 ADGRF5

5.23e-0519515067f9b7f15006610ad591063d90e90367bd6083c7f
ToppCellfacs-Heart-RA-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SEMA3F FLT4 CEMIP2 PIK3C2B ADGRF5 FAM124B

5.23e-05195150630c75761079fa1e1a3b84d23c88a222f459d5ce5
ToppCellBronchial-NucSeq-Stromal-Schwann-Schwann_Myelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CACNA1A PDE9A FAM178B CUBN FANCI LRRC8B

5.38e-051961506efeb272bc9e37e60d15d056b7574991c5c7501bc
ToppCell356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

GABRE DTX1 AKR1C1 SRGAP3 OSBPL1A KCTD18

5.38e-051961506b04ca69b0ed44e09c989b575f747e1e819cd8008
ToppCell356C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

GABRE DTX1 AKR1C1 SRGAP3 OSBPL1A KCTD18

5.38e-051961506a31e227de2dc077b81881295b012d22fedbd65ed
ToppCell10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

VWA5B2 SEMA3F NID2 FLT4 ADGRF5 FAM124B

5.53e-051971506a312d9cf4ced949307eb9620be4eed926300b892
ToppCellBronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ATP13A4 ERBB4 SCEL DNAH14 DUOX1 ADGRF5

5.85e-051991506725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCellParenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ATP13A4 ERBB4 SCEL DNAH14 DUOX1 ADGRF5

5.85e-0519915068587bd98de7767a575088afbea07a1feb4516b9b
ToppCellFibroblasts-HLA-DRA_high_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

PCSK5 NID2 PARP14 KSR1 KIAA1755 PLAU

5.85e-051991506fcbb3a9c0f4c5b4c1f09db24b9f50cc1166fa43b
ToppCellCOVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type

ATP13A4 DOCK8 SCEL PARP14 CEMIP2 DUOX1

5.85e-051991506155b03b859157013e9142e9248551369127d9204
ToppCell21|World / Age, Tissue, Lineage and Cell class

HCAR2 DOCK8 FAM178B EDN2 HCAR3 TSPO2

5.85e-0519915068c6517243168de4134e06dbe16ca89b1c2a73179
ToppCellLPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

NID2 ATP13A4 ABCA4 SCEL PTPRU FLRT3

6.02e-052001506ddfb1f006365bf16203ee49f20200f68220cc288
ToppCellLPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DTX1 UGDH SLA2 CMKLR1 FAM124B

8.79e-0513315052ec3490cbf60152c3cece95eb566d749c9666517
ToppCelldroplet-Heart-nan-24m-Hematologic-erythrocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PAQR9 PIDD1 TSPO2 BMP15

1.08e-0473150430374f4d30519ca8cd9582da1f9f906420e50244
ToppCellCOVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type

CACNA1A STXBP5L CUBN CNTNAP5 KLK5

1.08e-041391505a1945b07f177cde40e7eea03a19236ce76165857
ToppCellLPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CSMD2 WDR86 CMKLR1 CSMD1 GPAT2

1.36e-0414615052ac9b487a7991fdc15444aeb93533030e09825bb
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ATP13A4 ABCA4 ITGA2B TERT AKR1C1

1.59e-04151150516fc903fc71e25717b9908416f0bcd29c0a65a61
ToppCelldroplet-Lung-nan-3m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CDC45 FANCI GPR68 WDR86 FLRT3

1.64e-04152150577b319f594d5e4df29034bbf69c7490076f89dd3
ToppCellmild_COVID-19_(asymptomatic)-NK_CD56bright|World / disease group, cell group and cell class (v2)

PDE9A ETNK2 GZMK WDR86 IL17RD

1.70e-041531505aff5c8ab1fb4ebc324cec02cf562b7484bb10db8
ToppCellfacs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

VWA5B2 FLT4 IL20RA CEMIP2 ADGRF5

1.80e-0415515058fdda4e3657ac56188ae88ed3caf145f4d9d1567
ToppCellsaliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

NEMP1 NDST1 KDM5B VAC14 INTS13

1.86e-041561505abea3c183d32062b009a79a2bdf861021989c7ef
ToppCellHippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Lhx1_(Cajal-retzius)|Hippocampus / BrainAtlas - Mouse McCarroll V32

PIDD1 BDKRB2 GARIN2 P2RX5

1.95e-048515042c94ff338633c39edb4a3a69a04be33db764c586
ToppCellHippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Lhx1_(Cajal-retzius)-|Hippocampus / BrainAtlas - Mouse McCarroll V32

PIDD1 BDKRB2 GARIN2 P2RX5

1.95e-04851504f9e874ae2b3eadf58fbbe7367c5f498a357166ca
ToppCell390C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|390C / Donor, Lineage, Cell class and subclass (all cells)

FAM178B ITGA2B CDC45 FANCI CDC20

2.03e-0415915050fbfdb18b7ed4bde077add13f2b3636e144b254f
ToppCellCOVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type

CACNA1A STXBP5L CSMD2 CNTNAP5 CSMD1

2.03e-0415915055335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

GABRE ATP13A4 ERBB4 ADGRF5 WDR86

2.03e-0415915058680b054622f573a82b1625fb93c2d5db81d1034
ToppCell5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VWA5B2 CACNA1A TERT TMEM151A SEZ6

2.21e-041621505478cf560ef33c5c324142c76417447d4a571a2c9
ToppCellPND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ZFPM1 CDC45 PLAU ADGRF5 IL17RD

2.27e-0416315053efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622
ToppCell367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

TMPPE PCSK5 SPAG8 FAM20B NAA16

2.34e-0416415054ade97931ae1780af7836d988fe117a10b3e88a1
ToppCellfacs-Marrow-KLS-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PAQR9 FLT4 CUBN TSPO2 KIAA1755

2.41e-0416515054f95c2fe5ab4416c736fe0d1936695a2b26777eb
ToppCell390C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

PIDD1 CDC45 FANCI ELOVL3 CDC20

2.41e-041651505a5c3af634d2698f9a01cf074791756b7669f9fff
ToppCellfacs-Marrow-KLS-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PAQR9 FLT4 CUBN TSPO2 KIAA1755

2.41e-0416515053e913b49a868fdd5589200ae3e9be77c0938ba14
ToppCellfacs-Lung-nan-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ATP13A4 SCEL SPAG8 ST14 FLRT3

2.47e-04166150511b0ae82b3068ef91715dbdd49fe8e9791b4a480
ToppCell5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HCAR2 LCN12 AKR1C1 CNTNAP5 CYP4X1

2.47e-0416615059e98e6070055bfc780becee52d77830e06b6d854
ToppCellfacs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ATP13A4 SCEL SPAG8 ST14 FLRT3

2.47e-041661505fcc1aec31ebd39432d4cb284dc8fadf34e3c566a
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CACNA1A STXBP5L CUBN CSMD2 CSMD1

2.54e-0416715053edb0570e583bb527165bcd8a4c25a042054043b
ToppCell5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HCAR2 CAMTA2 BDKRB2 EDN2 TMEM151A

2.54e-041671505d1a13d6ada572d8ddb2da95e6e122d2b705fad7f
ToppCellfacs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT4 TTPAL SCEL KSR1 FANCI

2.54e-041671505961e722442d786ab15d1e490941d2be265a9057a
ToppCelldroplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PAQR9 FLT4 CDC45 BMP15 SMAD9

2.54e-041671505bad33497ceeab968a7eb8a48b921c6f936390743
ToppCellSevere-Lymphoid-NK-CD8_T|Severe / Condition, Lineage, Cell class and cell subclass

TRBV12-5 SRGAP3 GZMK CHST12 SLA2

2.54e-0416715058d41015871616ab7eced5104cd8f70d0efe504f2
ToppCellfacs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT4 TTPAL SCEL KSR1 FANCI

2.54e-0416715053760efc35d4e7e9c2da1a20f9795ddea397e2206
ToppCellcontrol-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

INPPL1 CSMD2 ITPR2 CNTNAP5 ADGRF5

2.62e-041681505327b02f19f4a8607c033203824fdc60a1254331f
ToppCell390C-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells)

MAN2B1 PIK3C2B SLA2 ZFYVE26 GPAT2

2.62e-0416815058459d0a1bf6d4b5c83001097331f8b78fceb9305
ToppCell367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)

TMPPE INPPL1 SPAG8 FAM20B NAA16

2.62e-0416815052fb2d916eb5000a637240d38e47a9b4f61f9f83f
ToppCell3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-NK_T_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DOCK8 GPR68 GZMK CHST12 SLA2

2.62e-041681505b4b73f3fc9f4c3d87ca0a63ff8b2842141ccd0e6
ToppCell343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells)

BDKRB2 EDN2 FANCI WDR90 CDC20

2.69e-041691505a949f547b53126a208819bade74a1ac9b2a36ea7
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK8 ZSWIM6 ITPR2 CNTNAP5 ADGRF5

2.69e-0416915052a21f2cef959526bfe3c8f081f4f7e9dd4e01a37
ToppCellfacs-Lung-24m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FBXO48 TMPPE SCEL SLA2 CDC20

2.69e-041691505dbf9b1d52b29bf4b60bd23012cc1ea82d344747f
ToppCell343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells)

BDKRB2 EDN2 FANCI WDR90 CDC20

2.69e-041691505195d5cd60d646ac6d40a3321b2f739917e7aef14
ToppCellfacs-MAT-Fat-3m-Epithelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ITGA2B CNTNAP5 TSPO2 TMEM151A

2.75e-04931504dbfaa7f23d25f5c286ab7ca3ca795b734cb95153
ToppCellfacs-MAT-Fat-3m-Epithelial-epithelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ITGA2B CNTNAP5 TSPO2 TMEM151A

2.75e-049315040d6d1d8dd9c91ba31eb35a4b5979d087890936c1
ToppCellfacs-MAT-Fat-3m-Epithelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ITGA2B CNTNAP5 TSPO2 TMEM151A

2.75e-04931504abffb1fd5a919b7c08e62e1c3c08a8dd8783a4ca
ToppCellfacs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMPPE PTPRU FANCI PLAU WDR90

2.84e-041711505913bae728b5e653771a27c79a309eb023699f1d0
ToppCellfacs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMPPE PTPRU FANCI PLAU WDR90

2.84e-041711505f28b2336057e353b96a6ff4581ec9fd0ca0789d9
ToppCell5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HCAR2 DOCK8 HCAR3 GPAT2 LRRC75A

2.91e-041721505c8ea80042faf923b08ff03d73100533d521d73ef
ToppCellPND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TMPPE DIPK2A FANCI UGDH CDC20

2.91e-04172150529c8510f26527d487d0fc3543102d067cdb281a6
ToppCellGlobus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

VWA5B2 GPR68 CYP4X1 CAMTA1 SMAD9

2.99e-0417315057e3897868dd3f6e4974f593c60649a543ffc8693
ToppCellfacs-Lung-EPCAM-24m-Lymphocytic-lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMPPE SRGAP3 WDR90 CABIN1 KCTD18

2.99e-0417315056e92983d9f8a2a37f23e60a0d5bb1738217897bc
ToppCell3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VWA5B2 CACNA1A STXBP5L IL20RA TMEM151A

2.99e-04173150546ed379571385684145b5cb6dd4ae340ac546e64
ToppCellfacs-Lung-EPCAM-24m-Lymphocytic-Alox5+_Lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMPPE SRGAP3 WDR90 CABIN1 KCTD18

2.99e-0417315054c788c1dad1da495b3b5c10f95e779848dfe85dc
ToppCellPND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D|PND01-03-samps / Age Group, Lineage, Cell class and subclass

FLT4 ANKRD50 CEMIP2 PIK3C2B ADGRF5

3.07e-041741505b4f3f5334803e5903bc496decf923f2e44f7fa3c
ToppCellfacs-Limb_Muscle-Muscle_Diaphragm-18m-Myeloid-new-cluster|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DOCK8 IL20RA ST14 CHST12 CDC20

3.07e-041741505718e14d9a4264456459bec4c062c94c3a848d43a
DrugNaDPA

PCSK5 ABCA4 FANCL PTPRU CHST12

1.31e-06301475CID000446780
Diseasetrimethylamine-N-oxide measurement

CUBN ITPR2 INTS13

3.66e-05141403EFO_0010541
Diseasesyndromic intellectual disability (implicated_via_orthology)

KDM5B UBE2A UBE2B

5.60e-05161403DOID:0050888 (implicated_via_orthology)
DiseaseLiver Cirrhosis, Experimental

PAQR9 RMND5B NID2 INPPL1 ITGA2B AKR1C1 ST14 CEMIP2 DIPK2A GPR68 PLAU PLG SEZ6

8.50e-0577414013C0023893
Diseaseprostate cancer (is_marker_for)

KDM3A KDM5B ERBB4 TERT PLAU SMAD9

1.04e-041561406DOID:10283 (is_marker_for)
DiseaseAlzheimer disease, gastroesophageal reflux disease

CACNA1A SEMA3F PTPRU VAC14 CNTNAP5 CHST12 CAMTA1

1.13e-042281407EFO_0003948, MONDO_0004975
Diseasekallikrein-8 measurement

KLK9 KLK5

3.31e-0461402EFO_0020516
Diseaseintellectual disability (implicated_via_orthology)

NDST1 KDM5B ITGA2B NAA16

4.54e-04751404DOID:1059 (implicated_via_orthology)
DiseaseLung diseases

PCSK5 DOCK8 TERT SMAD9

5.27e-04781404C0024115
Diseasetongue squamous cell carcinoma (is_marker_for)

ERBB4 FANCL FANCI

7.22e-04371403DOID:0050865 (is_marker_for)
Diseasewaist-hip ratio

PCSK5 NID2 NDST1 HCAR2 ERBB4 DTX1 SCEL BIRC6 SLC35F5 HCAR3 PIK3C2B SRGAP3 ADGRF5 FAM124B IL17RD

7.43e-04122614015EFO_0004343
Diseaseductal carcinoma in situ (is_marker_for)

ERBB4 TERT ST14

8.43e-04391403DOID:0060074 (is_marker_for)
Diseaseinterventricular septum thickness

ITPR2 INTS13

9.81e-04101402EFO_0009287
Diseaseblood copper measurement

ERBB4 SCEL AGO4

1.74e-03501403EFO_0007578
DiseaseFanconi anemia

FANCL FANCI

1.96e-03141402cv:C0015625
DiseaseBipolar Disorder

DAOA CACNA1A ERBB4 PDE9A ACADS BDKRB2 HCAR3 CSMD1

2.05e-034771408C0005586
DiseaseHypotension

BDKRB2 EDN2 PLAU

2.06e-03531403C0020649
Diseasepolyp of colon

NID2 PIK3C2B SMAD9

2.41e-03561403MONDO_0021400
DiseaseMalignant neoplasm of skin

HCAR2 ERBB4 HCAR3

2.80e-03591403C0007114
DiseaseSkin Neoplasms

HCAR2 ERBB4 HCAR3

2.80e-03591403C0037286
DiseaseIdiopathic hypogonadotropic hypogonadism

FLRT3 IL17RD

3.25e-03181402C0342384
DiseaseBone marrow hypocellularity

FANCL FANCI

3.25e-03181402C1855710
Diseaserenal cell carcinoma (is_marker_for)

ERBB4 TERT ST14 PLAU

3.29e-031281404DOID:4450 (is_marker_for)
Diseasetransitional cell carcinoma (is_marker_for)

ERBB4 TERT PLAU

3.37e-03631403DOID:2671 (is_marker_for)
Diseaseresponse to methotrexate, juvenile idiopathic arthritis

CMKLR1 CSMD1

3.63e-03191402EFO_0002609, GO_0031427
DiseaseUsual Interstitial Pneumonia

TERT PLAU

3.63e-03191402C4721509
DiseaseHamman-Rich Disease

TERT PLAU

3.63e-03191402C4721508
Diseaseage at onset, smoking initiation

SCEL ITPR2

3.63e-03191402EFO_0004847, EFO_0005670
DiseaseHemorrhage

BDKRB2 PLAU

4.02e-03201402C0019080
DiseaseFamilial Idiopathic Pulmonary Fibrosis

TERT PLAU

4.02e-03201402C4721952
Diseasecongenital heart disease (implicated_via_orthology)

UBE2A UBE2B NAA16

4.36e-03691403DOID:1682 (implicated_via_orthology)
DiseaseDeep Vein Thrombosis

PLAU PLG

4.42e-03211402C0149871
DiseaseVenous Thrombosis

PLAU PLG

4.42e-03211402C0042487
DiseaseIdiopathic Pulmonary Fibrosis

TERT PLAU

4.42e-03211402C1800706

Protein segments in the cluster

PeptideGeneStartEntry
LCVAIVHYNQPEWLS

CACNA1A

501

O00555
CYADTIHWQDIVRNP

ERBB4

156

Q15303
HNVTACVISYPSLIW

BDKRB2

206

P30411
QVCSILWSPHYKELI

CDC20

401

Q12834
SICLYLPQEQLTHWA

C6orf62

201

Q9GZU0
SIIPTFHRRCYWLLQ

CAMTA1

156

Q9Y6Y1
FHRRCYWLLQNPDIV

CAMTA1

161

Q9Y6Y1
YPNTLLRTWCLVLHS

BIRC6

2711

Q9NR09
APYDNNLHCTWIIEA

CSMD1

1296

Q96PZ7
NNLDCTWRISLPIGY

CSMD1

1996

Q96PZ7
YHLWSEAIPLCQALS

CSMD2

2516

Q7Z408
TLYLPHILCFAWQDR

ABCA4

771

P78363
ALCPRAWRQLHTIYQ

ACADS

16

P16219
QPWYSVEIHSACTVQ

ATP13A4

996

Q4VNC1
LIDPQWVLTAAHCQY

GZMK

56

P49863
TIALLALVCWYVHRN

FLRT3

541

Q9NZU0
RCYWLLQNPDIVLVH

CAMTA2

131

O94983
YFCHLDIIWVNTPEQ

EDN2

61

P20800
CRPLTITELYHAVWT

ANKRD50

361

Q9ULJ7
TSRPSHYQVLWDDNC

AGO4

761

Q9HCK5
WALLQNPNRHYQSLC

ADCY10

1326

Q96PN6
IRQCWHNYPFQPLSS

CERS5

171

Q8N5B7
SLKLPIAVSCYWLQH

ASTE1

461

Q2TB18
HPCVLLKLYSDEQWV

CPNE6

41

O95741
RLPLQWVDIAHLCLY

MTF2

261

Q9Y483
QLLQSAFRIYNCTWP

ITPR2

1511

Q14571
LKWCTPRTNNIELHY

INTS13

316

Q9NVM9
CSIEQAWCLYTPVIH

MFSD8

401

Q8NHS3
AWCLYTPVIHLAQFL

MFSD8

406

Q8NHS3
LRVCNSYWSREHPSL

DUOX1

361

Q9NRD9
IQHCLAWYKNTVIPL

FANCI

671

Q9NVI1
HLQRSLCPWVSYLPQ

DAOA

76

P59103
TINSHVVILLPWECY

OR2T1

21

O43869
LNLVLPCLEYHNNTW

KIAA0100

2141

Q14667
YACHDQVAVTILWSP

IL17RD

86

Q8NFM7
VYSPSQQRWLHCDAC

NGLY1

341

Q96IV0
QHCDTWSYVLIPAAQ

LCN12

86

Q6JVE5
WLLHTSGTQNCEVYR

HCAR2

256

Q8TDS4
LQHNGPWKVLCSLYS

KIAA1755

491

Q5JYT7
LCRQLTYHLSPHSQW

LRRC75A

136

Q8NAA5
PSAELYVLCRILHDW

ASMTL

516

O95671
QNTYCFPHSLRWIVS

GAPVD1

271

Q14C86
LQLTRFNLSCHVEPW

BMP15

141

O95972
PINERSFICNYKQHW

ATXN3L

106

Q9H3M9
YCLYPARETQLQWLH

ETNK2

296

Q9NVF9
WYRLCQQEGHLPDSS

FBXW8

156

Q8N3Y1
LLPVCRTRVYTNHWA

PCSK5

26

Q92824
LSHDWLCYLAPEIVR

KSR1

771

Q8IVT5
NLDAAVYSPRTQWIH

MMP19

336

Q99542
NPVTLRRWLFCVHDN

PDE9A

291

O76083
INSNNPWLHECLIRF

NAA16

701

Q6N069
CTKNLEHPIQWLYIT

NEMP1

311

O14524
HEWLSGRYSNICSPI

FBXO48

116

Q5FWF7
CGIWYRSERNLQAHL

ZFPM1

246

Q8IX07
ALQNRCLVPGWYATH

NDST1

746

P52848
STWQQGRLCIHVYRL

GABRE

466

P78334
DWLPLGRQCVEHYRL

KDM5B

606

Q9UGL1
LYCGAVLVHPQWLLT

KLK5

91

Q9Y337
LLEHNEAYTWTNPTC

OSBPL1A

696

Q9BXW6
WPEDLISLTKQLHCY

NBAS

1621

A2RRP1
LNEHSRWRPYTATVC

DTX1

31

Q86Y01
HTLVLTWLEPNTLYC

IL20RA

201

Q9UHF4
SCLKLWHNNIAYIPA

LRRC8B

636

Q6P9F7
PNCVWVEYADRLLQH

OXLD1

96

Q5BKU9
YLQQRLGWHVDCTRL

PAQR9

191

Q6ZVX9
TLQWEPLGYNVTRCH

PTPRU

401

Q92729
ACLPDIYVLLKQWTH

PIK3C2B

866

O00750
PTICERWRENLLEHY

NID2

1016

Q14112
SWNLDCRYVLHVVAP

PARP14

1081

Q460N5
VCNKPTVWVLHYLNT

KCTD18

136

Q6PI47
TYPSNLNCSWHVLVQ

CUBN

2111

O60494
QCDHVQYTLVPVSGW

CDC45

41

O75419
LDSLQHSPWQCYPTQ

FAM124B

86

Q9H5Z6
TPHYWLCDNRLLCLQ

KDM3A

941

Q9Y4C1
IERYDPHQNQWTVCR

KLHL28

496

Q9NXS3
DHWPCLDNLITVLYT

CABIN1

156

Q9Y6J0
PHVRDCVQTYIREWL

DOCK8

116

Q8NF50
VSILTYIWRQDQGCH

ELOVL3

216

Q9HB03
YAVCQNLLSRHATWR

DIPK2A

361

Q8NDZ4
SWILYCLALNPEHQE

CYP4X1

326

Q8N118
RRLCYFLWSLEQHIP

GPAT2

91

Q6NUI2
YLIRHPSCVNVSKWN

CEMIP2

971

Q9UHN6
SRWRQCQYVSTHLEP

DNAH14

2886

Q0VDD8
WCSQVVRLYPGQRHL

MAN2B1

696

O00754
RCTFQQSLIYWLHPA

DONSON

211

Q9NYP3
IHSLSPWCATRAVYN

ELSPBP1

46

Q96BH3
TTWIQERCREYHIPC

FZD3

451

Q9NPG1
NISILENKLCHWAYP

KLK9

166

Q9UKQ9
RKAIQISQQTPYWHC

MAU2

131

Q9Y6X3
ISQQTPYWHCRLLFQ

MAU2

136

Q9Y6X3
PSLLNDNQWHYVRAE

CNTNAP5

866

Q8WYK1
TYLEEEAPQRLWAHC

PIDD1

426

Q9HB75
NHYCPIFRLGSVIRW

P2RX5

226

Q93086
ICSLPFWLQYVLQHD

GPR68

71

Q15743
VCFEHYPIQAWQRAI

GPR68

171

Q15743
YSQWLASRHEANLLP

GAS2

21

O43903
CLSYQQLLREHLWIG

HMGCLL1

11

Q8TB92
IYLHNRANWVTVGIC

GARIN2

61

Q8N9W8
QWRCYARLVNPQHVF

SZT2

1121

Q5T011
LYRSWCHNPVTTVSL

VAC14

621

Q08AM6
SLWEQRRLPATHCFQ

RIN1

611

Q13671
CLPWNSATVLQQTYH

PLAU

91

P00749
VADRVPNYTSWSQHC

SPAG8

221

Q99932
LGRQNWHCLRETYET

PPP4R1

656

Q8TF05
FIVTLLCHYNNWDPV

SLC35F5

466

Q8WV83
LIQPWNRTHLYVCGT

SEMA3F

121

Q13275
HCLDNGWLYISPRLT

SLA2

151

Q9H6Q3
IIPHYSLARWLLCNG

TMEM161B

21

Q8NDZ6
LLCNGSLRWYQHPTE

TMEM161B

31

Q8NDZ6
QPFHQICLYEWLRGL

FANCL

331

Q9NW38
YLNTWKNRCESIHPS

IQCA1L

401

A6NCM1
YIRWQELLTHCQPQA

FAM178B

656

Q8IXR5
WLLHTSGTQNCEVYR

HCAR3

256

P49019
AYHSRCVDPWLTQTR

RNF167

251

Q9H6Y7
RILWKSYPETHIICN

INPPL1

691

O15357
LTQGSYLHQRVCWRL

TELO2

241

Q9Y4R8
EPIHCIVWAKYLFNQ

UBA2

181

Q9UBT2
LEWHICSNRQLVPSY

TMEM151A

346

Q8N4L1
VTELSWHSCRQLLYQ

SUPT7L

146

O94864
WHSCRQLLYQAVATI

SUPT7L

151

O94864
YQRPLDQFVLQSHAW

ITGA2B

946

P08514
HTTNSQVRWEYCKIP

PLG

336

P00747
LQDYIQLLHPWCQVN

NUP160

891

Q12769
ERITYCHLPFQSKWL

STXBP5L

156

Q9Y2K9
YHRQDVTSTPCWIEI

SMAD9

426

O15198
YGWPRERCLHNLICQ

ADGRF5

126

Q8IZF2
YTSKLWCNSHRPELV

AKR1C1

81

Q04828
DRCISVLLPVWSQNH

CMKLR1

136

Q99788
HWRQVYRLCHPCQID

CHST12

321

Q9NRB3
LQLLVNYHSCRRSWP

TTPAL

96

Q9BTX7
AVQALCAVYEHWVPR

UGDH

191

O60701
YSCADPQWHVLRVAA

WDR90

811

Q96KV7
ELRILTNWGHPEYTC

SUN2

691

Q9UH99
YLLSPVNCWYLVLHQ

SRGAP3

91

O43295
VNCWYLVLHQTRRES

SRGAP3

96

O43295
WYHSVFACPILRQQT

RMND5B

331

Q96G75
RPCLYLNWQDTAVLA

TRIM51

36

Q9BSJ1
QAGDSIWIYRQTIHC

SCEL

661

O95171
APLYQCCIIRVSTWN

FAM20B

326

O75063
ISPNWLVSAAHCYID

ST14

646

Q9Y5Y6
PLLHDALYLQCETTW

FLT4

196

P35916
SICLDILQNRWSPTY

UBE2A

86

P49459
WCLHYIICSQVSNPL

TMCO6

261

Q96DC7
NYSNNLTCHWLLEAP

SEZ6

436

Q53EL9
ITYPLVHLANWLCGL

TMEM168

646

Q9H0V1
WDQNLQLHLLCYSPA

VWA5B2

1226

Q8N398
YPRWFTLSHIESQQC

ZSWIM6

821

Q9HCJ5
TCEAAYRVLHWENPV

ZFYVE27

166

Q5T4F4
SALTYHLWRDSLCPV

TSPO2

146

Q5TGU0
RCQPILGHNTVFWYR

TRBV12-5

41

A0A1B0GX78
TRLQELCYQWLRPHV

ZSCAN9

71

O15535
LCYQWLRPHVSTKEQ

ZSCAN9

76

O15535
IPDVHLYRLCWSLRN

SLC5A1

551

P13866
HRNCVLTLAYSAPWD

WDR86

136

Q86TI4
VQDICAQWLLTSHPR

ZFYVE26

2516

Q68DK2
HINPYLVLECAWRVS

TRRAP

2846

Q9Y4A5
YLPHEELFCSQIWQQ

ZNF45

96

Q02386
PSEAVQWLCHQAFLL

TERT

1066

O14746
SICLDILQNRWSPTY

UBE2B

86

P63146
LYIWRSTVSNLCHSP

TMPPE

61

Q6ZT21